KFSH Reports 95.2% Five-Year Survival Rate for Children with Wilms Tumor
King Faisal Specialist Hospital & Research Centre (KFSH) reported a five-year survival rate of 95.2% following diagnosis among children with Wilms tumor, the most common kidney cancer in children. The findings are based on an analysis of 104 children diagnosed and treated at KFSH, with long-term follow-up enabling assessment of treatment outcomes.
The medical team determines each child’s treatment plan based on the tumor stage, test results, overall health, and, when needed, tumor characteristics. Treatment typically involves surgery and chemotherapy, with radiation therapy used in some cases. Surgery may involve removing all or part of the affected kidney, depending on the child’s condition and tumor characteristics.
Wilms tumor develops in the kidneys during childhood and may initially progress without obvious symptoms. In some cases, it is discovered after a lump or swelling is noticed in the abdomen. Other possible signs include abdominal pain, blood in the urine, high blood pressure, fever, and loss of appetite or weight.
Consultant in Pediatric Hematology and Oncology at KFSH Dr. Awatif Alanazi explained that treating Wilms tumor requires attention to kidney health alongside cancer treatment. Because the disease occurs early in life, preserving kidney function is an important consideration throughout treatment.
Long-term follow-up of Wilms tumor cases at KFSH provides clinical data that support the evaluation of treatment practices and outcomes and help improve care for children with the disease.
KFSH ranked first in the Middle East and Africa and 12th globally among the world’s top 250 academic medical centers for 2026. It was also recognized as the most valuable healthcare brand in Saudi Arabia and the Middle East by Brand Finance in 2026 and included in Newsweek’s World’s Best Hospitals, World’s Best Smart Hospitals, and World’s Best Specialized Hospitals lists for 2026.



